ALK-positive anaplastic large cell lymphoma of skeletal muscle masquerading as soft tissue sarcoma
- 1 Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Jodhpur, India
- 2 Department of Paediatrics, All India Institute of Medical Sciences, Jodhpur, India
- Correspondence to Dr Vikarn Vishwajeet; vikarn.pmch@gmail.com
Abstract
Anaplastic large cell lymphoma (ALCL) is a subtype of T cell non-Hodgkin’s lymphoma and can present as an extranodal disease. Primary ALCL of skeletal muscle is rare. We report a case of ALK-positive ALCL involving the left thigh and anterior chest wall in a 12-year-old male child. The fine needle aspiration cytology from the lesion showed cellular smears with singly scattered and occasional clusters of large pleomorphic atypical cells. A diagnosis of poorly differentiated malignant neoplasm was rendered. On core biopsy, the histomorphological features posed a diagnostic challenge with a myriad of morphological mimickers. The diagnosis was established by excluding specific entities by relevant immunostains and confirming the diagnosis by strong expression of CD30 and ALK on immunohistochemistry. Fluorescence in-situ hybridisation confirmed the characteristic t(2:5) translocation. Presentation of ALCL with skeletal muscle involvement is uncommon, and the diagnosis relies on broadening the diagnostic possibilities and judicious use of immunohistochemical markers.
Background
Anaplastic large cell lymphoma (ALCL) constitutes 2%–8% of all adult non-Hodgkin’s lymphomas (NHLs) and up to 30% of all paediatric NHLs. It was first described by Stein et al in 1985 and is characterised by the proliferation of anaplastic lymphoid cells having large pleomorphic lymphoid cells, often having the variable number of ‘hallmark cells’ represented by irregular horseshoe-shaped nuclei.1 ALCL can involve extranodal sites, including soft tissue, skin, bone, lungs and liver.2 Because of the cohesive growth pattern and marked cytomorphological variation noted in the cells of ALCL, a range of non-haematological malignancies such as carcinomas, sarcomas, germ cell tumours and melanomas can enter into the differential diagnosis, particularly in the extranodal sites. ALCL involvement of skeletal muscle is infrequent, and a few cases have been reported in the literature.3 4 Herein, a case of ALCL of extranodal site mimicking high-grade sarcoma is presented.
Case presentation
A 12-year-old male child presented to the outpatient clinic with insidious onset swelling in the medial side of the left upper thigh (figure 1A). The swelling measured 13×10 cm and was painless and gradually progressive for 1.5 months. However, it became painful for the last 5 days. He also had another swelling in the anterior chest wall for 1 month, measuring 12×10 cm (figure 1B). The skin over the swellings was excoriated with areas of reddish discolouration. Both the swellings were tender, firm, non-fluctuant, non-compressible and non-pulsatile. There was no significant medical history. On physical examination, he was afebrile and had a pulse rate of 118/min and respiratory rate of 22/min. There was no pallor, icterus, cyanosis, clubbing or oedema. Left inguinal lymphadenopathy was present, which was subcentimetric, mobile and non-tender; however, no axillary or cervical node enlargement was noted.
Swelling on the left upper thigh (A) and right chest wall (B).
The MRI showed a large well-defined lobulated heterogeneously hyperintense (T2) and hypointense (T1) signal lesion in the muscular plane (invading adductor longus, magnus muscles and abutting sartorius, gracilis, semimembranous, semitendinosus muscles, long head of biceps tendon and distal part of superficial femoral vessels) at the medial aspect of the left mid-distal thigh. On CT of chest mass, a heterogeneously enhancing solid mass lesion measuring 8×6.6×8 cm was seen at the upper anterior mediastinum with extrathoracic chest wall components. The intrathoracic mediastinal components showed loss of fat plane with upper mediastinal vessels, superior vena cava, arch of aorta, pulmonary trunk and trachea. The external chest wall swelling extended from right upper anterior part of the chest wall through the sternal region of the chest wall causing subtle erosion of the inner table of the manubrium. The mass showed heterogeneously enhancing solid areas with central non-enhancing necrotic areas.
The fine needle aspiration cytology from both chest and thigh sites was performed in an outside laboratory where it was reported as poorly differentiated neoplasm. We had received review slides from both the sites (chest wall and thigh) for second opinion. Smears from both the sites were highly cellular and showed singly scattered and occasional clusters of variably sized cells, predominantly small with a few intermediate to large atypical cells. The large pleomorphic cells had high nucleo-cytoplasmic ratio, coarse chromatin with two to three conspicuous nucleoli and a moderate amount of cytoplasm. An occasional cell with embryo-like nuclei (cells with lobulated nuclei) and some lymphoglandular bodies (cytoplasmic fragments of lymphoid cells seen in the background), mixed inflammatory infiltrate and haemorrhage were seen in the background (figure 2A,B). As no cell block was available, immunocytochemistry could not be performed. The case was reported as a small round cell tumour. Subsequently, biopsies from both the sites were performed, which showed similar morphology, showing a cellular tumour arranged in a solid, cohesive pattern with traversing thin fibrous septae. These tumour cells were predominantly small-sized cells to few intermediate to large-sized cells. The intermediate-sized cells had irregular nuclear margins, coarse chromatin, conspicuous nucleoli and scant to moderate cytoplasm. Some of the cells had embryoid-like morphology. Few atypical mitosis and apoptotic bodies were seen. A possibility of a small round cell tumour, with an initial consideration of rhabdomyosarcoma and Ewing’s sarcoma, was kept. However, an immunohistochemical panel comprising of desmin, myogenin, MyoD1 and CD99 was negative. Further immunohistochemistry (IHC) panel considering haematopoietic neoplasm (including myeloid sarcoma, Langerhans cell histiocytosis (LCH), histiocytic sarcoma and lymphoma), melanoma and poorly differentiated carcinoma was ordered. However, the tumour cells were negative for Pan-CK, CD21, CD1a, HMB-45, TdT, MPO and CD68, while these cells showed diffuse expression of CD45. Further, panel for lymphoma, including CD3, CD20, CD79a, CD4, CD5, CD8 and CD30, was applied. However, none of these markers, except CD30 and CD4, showed expression in tumour cells. After that, a diagnostic suggestion of ALCL was raised as ALCL is often known to show frequent loss of one or more T cell markers. IHC for ALK showed strong cytoplasmic staining in tumour cells (figure 3A–D). Based on these findings, a diagnosis of ALK-positive ALCL was considered. Fluorescence in-situ hybridisation testing from chest wall biopsy showed chromosomal abnormality t(2;5), corresponding to NPM1-ALK fusion transcripts. Bone marrow was not involved by the lymphoma. Systemic chemotherapy was initiated.
Singly scattered and loose cohesive clusters of malignant cells showing nuclear pleomorphism with enlarged nuclei, prominent nucleoli and moderate to abundant cytoplasm. Also note a subset of cells show irregular embryoid nuclei and occasional binucleation (A,B, ×400; (A) Giemsa stain; (B) H&E stain).
(A) Histological sections of the core biopsy show diffuse arrangement of tumour cells, several of which show irregular convulated embryoid nuclei. These cells show strong membranous expression of CD4 (B), membranous and golgi-zone positivity for CD30 (C) and cytoplasmic expression of ALK1 (D) (A–D, ×400; (A) H&E; (B–D) immunohistochemistry).
Discussion
The present case reports the uncommon presentation of ALCL with skeletal muscle involvement, which likely or probably be the primary, though lymph node primary could not be excluded entirely as NHL primarily affects the organs with lymphoid tissue, but it may involve almost every organ of the body (extranodal NHL), including the gastrointestinal tract, skin, orbit, bone and central nervous system, among others.5 Primary skeletal muscle involvement by NHL is relatively rare, accounting for less than 1% of extranodal lymphoma.6 Most of these lymphomas (>95%) are of B cell origin and commonly affect skeletal muscles of the lower extremity, pelvic region and upper arm.6 At the Mayo Clinic, among 7000 cases of malignant lymphomas diagnosed over a period of 10 years, only 8 cases initially presented as soft tissue masses in the extremities with a rate of 0.1%.7 Pecorella et al reviewed the scientific literature for cases of primary skeletal muscle NHL, excluding cases with concurrent nodal, visceral or systemic involvement and retrieved only 7 primary muscle ALCLs and 51 other lymphomas.4
The diagnosis of the present case was established on the biopsy tissue after careful exclusion of the morphological mimickers. Had there been material available for cell block preparation, a diagnosis might have been reached using the immunocytochemical studies.8 Rhabdomyosarcomas, the most common sarcoma in children and adolescents, show monomorphic round and occasional spindle cell morphology with evidence of myogenesis. The demonstration of skeletal muscle differentiation using immunohistochemical markers desmin, MyoD1 and myogenin is very useful in making the diagnosis.9 Classic Ewing’s sarcoma occurs in extraskeletal tissue in one-fifth of cases and is characterised by a uniform population of small round cells and strong membranous expression of CD99. However, the diagnosis of Ewing’s sarcoma and the Ewing family of tumours often requires cytogenetic studies.10 Among the histiocytic tumours of childhood, LCH can mimic ALCL. While evaluating the present case, strong CD45 positivity and absent CD20 and CD3 expression put LCH high on our diagnostic consideration. However, LCH shows characteristics folded, grooved or indented nuclei and moderately abundant slightly eosinophilic cytoplasm and requires confirmation of LCH cells by immunohistochemical expression of CD1a and/or langerin.11 Precursor lymphoid neoplasms, including T cell lymphoblastic lymphoma and B cell lymphoblastic lymphoma, show small to medium-sized cells having condensed to dispersed chromatin, variably prominent nucleoli and scant cytoplasm. These neoplasms frequently have blood and bone marrow involvement and express immaturity markers, particularly TdT.12 Although rare for the age and site for the present case, poorly differentiated carcinoma and melanoma were excluded after absent expression of cytokeratin and HMB-45, respectively.
ALCL accounts for approximately 10%–20% of childhood lymphomas, occurring commonly during the first three decades of life with male predominance.1 The WHO update of haematolymphoid malignancies includes two distinct variants of systemic ALCL based on ALK expression: ALK+ALCL and ALK−ALCL.1 The characteristic immunophenotype of ALCL includes CD30 expression along with variable expression of T cell markers. Among the T cell markers, CD3 expression is absent in more than 75% of cases, while CD2, CD5 and CD4 expressions are present in nearly 70% of cases. Nearly 10%–30% of cases show absent expression of all T cell markers.1 ALK+ALCL harbours the genetic alteration that involves translocation of the ALK gene on chromosome 2. The most common partner gene is the NPM1 gene on chromosome 5, which results in a translocation, t(2;5)(p23;q35). Other partner genes involved in ALK translocation include TPM3, ATIC, TFG17, among others.13 The cellular localisation of the fusion protein can be studied using ALK monoclonal antibodies for IHC.14 The present case had a cytoplasmic expression of ALK1 antibodies in tumour cells.
ALK not only serves as a diagnostic marker but as an independent prognostic marker as well. Patients with ALK-positive ALCL are approximately two decades younger and have a more favourable prognosis than those with ALK-negative ALCL, with a 5-year survival rate of 70%–80% for ALK-positive and 33%–49% for ALK-negative cases.2 15
Learning points
-
The present case reports the uncommon presentation of anaplastic large cell lymphoma (ALCL) with primary skeletal muscle involvement which can lead to a significant diagnostic challenge for the pathologist.
-
The diagnosis of the present case was established on the biopsy tissue after careful exclusion of the morphological mimickers.
-
The diagnosis of primary involvement of skeletal muscle by ALCL relies on broadening the diagnostic possibilities and judicious use of immunohistochemical markers.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors DG, VV and PAE assisted in pathology analysis, critically reviewed the literature and drafted the manuscript. MR provided the clinical details and drafted the manuscript.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer